Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Melissa Itsara"'
Autor:
Kathleen M. Giacomini, Katherine K. Matthay, Steven G. DuBois, Daphne A. Haas-Kogan, Sabine Mueller, William A. Weiss, Henry F. VanBrocklin, Youngho Seo, Michelle K. Tadano, Ethan G. Geier, Xiaodong Yang, Melissa Itsara, Swati S. More
Supplementary Figures S1-S6.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20a16a1d9af66a155f8b36657648e12e
https://doi.org/10.1158/1078-0432.22442561
https://doi.org/10.1158/1078-0432.22442561
Autor:
Kathleen M. Giacomini, Katherine K. Matthay, Steven G. DuBois, Daphne A. Haas-Kogan, Sabine Mueller, William A. Weiss, Henry F. VanBrocklin, Youngho Seo, Michelle K. Tadano, Ethan G. Geier, Xiaodong Yang, Melissa Itsara, Swati S. More
Purpose: Histone deacetylase (HDAC) inhibition causes transcriptional activation or repression of several genes that in turn can influence the biodistribution of other chemotherapeutic agents. Here, we hypothesize that the combination of vorinostat,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::844c351f6d9aa54d80f79fb28959b053
https://doi.org/10.1158/1078-0432.c.6519260.v1
https://doi.org/10.1158/1078-0432.c.6519260.v1
Autor:
Suzanne S. Teuber, Melissa Itsara
Publikováno v:
Journal of Allergy and Clinical Immunology. 145:AB232
Publikováno v:
Journal of Allergy and Clinical Immunology. 143:AB197
Autor:
Xiaodong Yang, Henry F. VanBrocklin, Sabine Mueller, William A. Weiss, Youngho Seo, Daphne A. Haas-Kogan, Swati S. More, Katherine K. Matthay, Kathleen M. Giacomini, Melissa Itsara, Michelle K. Tadano, Steven G. DuBois, Ethan G. Geier
Publikováno v:
Clinical Cancer Research. 17:2339-2349
Purpose: Histone deacetylase (HDAC) inhibition causes transcriptional activation or repression of several genes that in turn can influence the biodistribution of other chemotherapeutic agents. Here, we hypothesize that the combination of vorinostat,
Autor:
Randall A. Hawkins, Katherine K. Matthay, Melissa Itsara, William A. Weiss, Hyo-Min Cho, Daphne A. Haas-Kogan, Shorouk Dannoon, Miguel Hernandez-Pampaloni, Chang-Lae Lee, Henry F. VanBrocklin, Youngho Seo, George A. Sayre, Hilla Wahnishe, Xiaodong Yang, Hee-Joung Kim
Publikováno v:
Medical Physics. 37:4861-4867
Purpose: A pretherapy 124I-metaiodobenzylguanidine (MIBG) positron emission tomography (PET)∕computed tomography (CT) provides a potential method to estimate radiation dose to normal organs, as well as tumors prior to 131I-MIBG treatment of neurobl
Autor:
W. Clay Gustafson, William A. Weiss, Grace E. Kim, Katherine K. Matthay, Melissa Itsara, Matthew R. Grimmer, Slava Yakovenko, Elise Charron, Yvan Chanthery, Christopher S. Hackett, Anders Persson
Publikováno v:
Science translational medicine. 4(115)
Neuroblastoma, a tumor of peripheral neural crest origin, numbers among the most common childhood cancers. Both amplification of the proto-oncogene MYCN and increased neoangiogenesis mark high-risk disease. Because angiogenesis is regulated by phosph
Autor:
Chang-Lae, Lee, Hilla, Wahnishe, George A, Sayre, Hyo-Min, Cho, Hee-Joung, Kim, Miguel, Hernandez-Pampaloni, Randall A, Hawkins, Shorouk F, Dannoon, Henry F, VanBrocklin, Melissa, Itsara, William A, Weiss, Xiaodong, Yang, Daphne A, Haas-Kogan, Katherine K, Matthay, Youngho, Seo
Publikováno v:
Medical physics. 37(9)
A pretherapy 124I-metaiodobenzylguanidine (MIBG) positron emission tomography (PET)/computed tomography (CT) provides a potential method to estimate radiation dose to normal organs, as well as tumors prior to 131I-MIBG treatment of neuroblastoma or p
Autor:
David D. Goldenberg, Kim N. Nguyen, Fredrik J. Swartling, Akiko Nishiyama, Jennifer Ayers-Ringler, Anders Persson, Mitchel S. Berger, Scott R. VandenBerg, Stanislava Yakovenko, Tracy R. McKnight, Romane Auvergne, William A. Weiss, Steven A. Goldman, Claudia Petritsch, Melissa Itsara, Fraser J. Sim, William B. Stallcup, Gabriele Bergers
Publikováno v:
Cancer Cell. (6):669-682
SummaryMalignant astrocytic brain tumors are among the most lethal cancers. Quiescent and therapy-resistant neural stem cell (NSC)-like cells in astrocytomas are likely to contribute to poor outcome. Malignant oligodendroglial brain tumors, in contra